Canal Biosciences

Health Care · Genomics & Genetic Testing

Overview

Learn howCanal's TrueLink® NGS technology safeguards your template without the need for end repair.

Funding and backers

Total raised
$2.3M
1 round on record
Latest round
$2.3M
Venture round · Mar 2026 · 7 mo ago
Team
1-10
employees, estimated range
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 18 Raised a round Venture round $2.3M · SEC Form D 2024 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Mar 2026 $2.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Canal Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Yu ZhengExecutive Officer, DirectorSEC Form D
Christopher BenoitExecutive Officer, DirectorSEC Form D
Jack PercoskieExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Global Brain
backs Rhelixa
Draper Associates
backs Basepair
Meta Planet
backs Basepair
Atinum Investment
backs Macrogen
Entrepreneurs Roundtable Accelerator
backs Basepair
better ventures
backs Qnomx
Similar startupsby what they do, their industry and backers
Rhelixa
ゲノム （ DNA ）、エピゲノム、トランスクリプトーム （ RNA ）を独自の技術で解析し、研究開発の効率・精度を格段に向上させます。次世代シーケンス（ NGS ）／ エピジェネティクス 研究の 実験デザイン から 情報 解析、論文化、事業化までオーダーメイドで支援します。.
QnomxFounded 2023
Reduce expert workload per NGS case by up to 85%. Qnomx leverages AI to streamline NGS interpretation and generate clinician-ready reports.
Basepair11-50 employees
Basepair offers advanced NGS data analysis platform for academic, commercial, and clinical research. Try it today!
seqWellVenture round $960k · 2 mo ago · 51-200 employees
SeqWell delivers true multiplexing NGS library prep solutions using stunningly simple workflows.
| Jumpcode GenomicsVenture round $3.5M · 2 yr ago · Founded 2016 · 51-200 employees
The majority of molecules sequenced are uninformative. Jumpcode Genomics is changing that by helping researchers boost usable NGS data.
Univ8 GenomicsVenture round · 2 yr ago
Bespoke NGS solutions for different clinical indications, without compromising in accuracy, content, performance or simplicity.

Financials

Total raised
$2.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 $2.3M Details

People

Yu Zheng
Executive Officer, Director
SEC Form D
Christopher Benoit
Executive Officer, Director
SEC Form D
Jack Percoskie
Executive Officer
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Lowell United States
HQ
Contact Information
1-10 est. staff
110 Canal Street, Lowell, MA 01852
company site